icometrix
icometrix is a global leader in AI-driven brain imaging solutions, founded in 2011 as a university spin-off. Their mission is to improve patient lives by providing data-driven insights and personalized care through artificial intelligence. The company offers a portfolio of AI solutions including icobrain, which analyzes brain MRI and CT scans for neurological disorders like multiple sclerosis, dementia, Alzheimer's, stroke, and traumatic brain injury. They also provide icompanion, a digital platform for MS patient monitoring, and icolung for lung analysis. icometrix has achieved FDA clearance and CE marking for its solutions, with icobrain being the first AI neuroradiology solution to receive U.S. reimbursement approval. The company is internationally active, integrated into over 300 clinical practices, and collaborates with healthcare providers and pharmaceutical companies for drug research evaluation.
icometrix
icometrix is a global leader in AI-driven brain imaging solutions, founded in 2011 as a university spin-off. Their mission is to improve patient lives by providing data-driven insights and personalized care through artificial intelligence. The company offers a portfolio of AI solutions including icobrain, which analyzes brain MRI and CT scans for neurological disorders like multiple sclerosis, dementia, Alzheimer's, stroke, and traumatic brain injury. They also provide icompanion, a digital platform for MS patient monitoring, and icolung for lung analysis. icometrix has achieved FDA clearance and CE marking for its solutions, with icobrain being the first AI neuroradiology solution to receive U.S. reimbursement approval. The company is internationally active, integrated into over 300 clinical practices, and collaborates with healthcare providers and pharmaceutical companies for drug research evaluation.